Skip to main content

Table 1 Disease, surgical procedure, and clinical outcome report TBR values indicate intraoperative probe measurements

From: PET probe-guided surgery: applications and clinical protocol

Case #

Diagnosis

Operation

Probe Utility

Time (hrs)

SUV

TBR

Count/Sec

1

Lymphoma

Excisional Biopsy, Groin

Localized the non-palpable target (A)

6

7.1

2.0

302

2

Recurrent non-Iodine avid Thyroid Cancer

Anterior Neck Dissection

Localized non-palpable metastatic lymph nodes (A)

6

6.4

1.5

166

3

Recurrent non-Iodine avid Thyroid Cancer

Central Neck Dissection

Localized the non-palpable target (A)

6

7.0

1.6

546

4

Adrenocortical Cancer

Sternotomy/Laparatomy Lung/Liver Resection

Localized difficult to access metastatic lymph nodes (A)

6

4.0

1.8

450

5

Ovarian Cancer

Exploratory Laparatomy Metastasectomy

Confirmatory (B)

4

39.8

1.5

297

6

Gastric Cancer

Gastrectomy Extended Node dissection

Localized surgically occult node (A)

4

6.1

1.8

150

7

Colon Cancer

Exploratory Laparatomy Periaortic Dissection

Localized difficult to access metastatic lymph nodes (A)

2

9.1

1.5

1067

8

Lung

Thoracotomy

Confirmatory (B)

4

4.0

1.5

1152

9

Lymphoma Axilla Lymph Node

Excision

Confirmatory (B)

6

4.4

1.8

125

10

Groin Lymphoma

Excision

Confirmatory (B)

4

4.9

2.2

172

11

GIST-Pertonial Implant

Exploratory cytoreduction

Confirmatory (B)

6

9.5

1.9

165

12

Recurrent non-iodine avid Thyroid Cancer

Central Neck Dissection

Localized non-palpable metastatic lymph nodes (A)

6

19.6

2.4

540

13

Lymphoma

Excisional Biopsy, Neck

Localized the non-palpable target (A)

6

7.7

3.8

173

14

Lymphoma

Excisional Biopsy, Groin

Localized the non-palpable target (A)

6

3.6

1.5

749

15

Gastrointestinal Stromal Tumor

Exploratory Laparatomy Liver Resection

Confirmatory (B)

6

4.3

1.5

690

16

Recurrent non-iodine avid Thyroid Cancer

Neck and Mediastinal Node dissection

Localized difficult to access metastatic lymph nodes (A)

6

7.7

1.7

361

17

Lymphoma

Excisional Biopsy, Axilla

Localized the non-palpable target (A)

6

3.3

1.8

828

18

Breast Cancer

Axillary Dissection

Confirmatory (B)

4

3.6

1.8

754

19

Colon Cancer

Liver Resection Exploratory Laparatomy

Confirmatory (B)

6

12.5

1.8

148

20

Branchial cancer

Excision

Localized the non-palpable target (A)

6

9.6

1.5

602

21

Colon Cancer

Laparatomy Celiac Node Dissection

Localized difficult to access metastatic lymph nodes (A)

4

6.1

2.0

127

22

Unknown Primary – Thigh Soft Tissue

Excisional Biopsy

Negative surgical exploration (C)

6

15.8

N/A

N/A

23

Colon Cancer

Liver Resection Exploratory Laparatomy

Confirmatory (B)

6

5.2

3.8

150

24

Colon Cancer

Exploratory Laparatomy Periaortic Dissection

Localized difficult to access metastatic lesions (A)

6

4.5

2.1

894

25

Head and Neck Cancer

Escisional biopsy

Localized the non-palpable target (A)

4

8

2

210

  1. Outcome Legend:
  2. (A): Category-A where the probe's use was instrumental and resulted in direct surgical benefit. (B): Category-B where the probe's use was confirmatory with no direct impact on surgical performance. (C): Category-C where the probe did not locate the image-positive lesion.